'State-Corporate Facilitated Harms of the Pharmaceutical Industry: A Gendered Perspective'

Research output: Contribution to journalArticle

13 Downloads (Pure)

Abstract

The pharmaceutical industry has long been recognised by criminologists as causing social harms towards individuals and groups, by engaging in unethical and illegal business practices in the pathological pursuit of profit (Braithwaite, 1984/2014; Bakan, 2004). This article argues that the neoliberal state is complicit and contributes to pharmaceutical harms due to its reluctance to effectively prohibit and sanction these (Tombs and Whyte, 2015). Neoliberal national healthcare politics and policies have also created rationale and opportunities for private profit creation by the pharmaceutical industry, and resultant social harms (Harvey, 2005; Dorling, 2014). Using a zemiological approach, this article specifically examines why women as healthcare recipients are disproportionately affected by pharmaceutical harms (Szockyi and Fox, 1996). It argues that women who experience social harms caused by the pharmaceutical industry are perceived primarily in relation to their reproductive and sexualised bodies, resulting in devaluation of their health and obscuring of state-corporate harms caused.
Original languageEnglish
JournalJustice, Power and Resistance: The Journal of the European Group for The Study of Deviance and Social Control.
Volume3
Issue number1
Publication statusAccepted/In press - 4 Feb 2019

Fingerprint

pharmaceutical industry
pharmaceutical
profit
devaluation
sanction
recipient
politics
health
experience
Group

Keywords

  • Gender
  • Neoliberalism
  • Pharmaceutical Industry
  • Profit
  • State-Facilitated Corporate Harm

Cite this

@article{8ed5941c9d3046119b16b2a9cf9a7df9,
title = "'State-Corporate Facilitated Harms of the Pharmaceutical Industry: A Gendered Perspective'",
abstract = "The pharmaceutical industry has long been recognised by criminologists as causing social harms towards individuals and groups, by engaging in unethical and illegal business practices in the pathological pursuit of profit (Braithwaite, 1984/2014; Bakan, 2004). This article argues that the neoliberal state is complicit and contributes to pharmaceutical harms due to its reluctance to effectively prohibit and sanction these (Tombs and Whyte, 2015). Neoliberal national healthcare politics and policies have also created rationale and opportunities for private profit creation by the pharmaceutical industry, and resultant social harms (Harvey, 2005; Dorling, 2014). Using a zemiological approach, this article specifically examines why women as healthcare recipients are disproportionately affected by pharmaceutical harms (Szockyi and Fox, 1996). It argues that women who experience social harms caused by the pharmaceutical industry are perceived primarily in relation to their reproductive and sexualised bodies, resulting in devaluation of their health and obscuring of state-corporate harms caused.",
keywords = "Gender, Neoliberalism, Pharmaceutical Industry, Profit, State-Facilitated Corporate Harm",
author = "Helen Baker",
year = "2019",
month = "2",
day = "4",
language = "English",
volume = "3",
journal = "Justice, Power and Resistance: The Journal of the European Group for The Study of Deviance and Social Control.",
number = "1",

}

TY - JOUR

T1 - 'State-Corporate Facilitated Harms of the Pharmaceutical Industry: A Gendered Perspective'

AU - Baker, Helen

PY - 2019/2/4

Y1 - 2019/2/4

N2 - The pharmaceutical industry has long been recognised by criminologists as causing social harms towards individuals and groups, by engaging in unethical and illegal business practices in the pathological pursuit of profit (Braithwaite, 1984/2014; Bakan, 2004). This article argues that the neoliberal state is complicit and contributes to pharmaceutical harms due to its reluctance to effectively prohibit and sanction these (Tombs and Whyte, 2015). Neoliberal national healthcare politics and policies have also created rationale and opportunities for private profit creation by the pharmaceutical industry, and resultant social harms (Harvey, 2005; Dorling, 2014). Using a zemiological approach, this article specifically examines why women as healthcare recipients are disproportionately affected by pharmaceutical harms (Szockyi and Fox, 1996). It argues that women who experience social harms caused by the pharmaceutical industry are perceived primarily in relation to their reproductive and sexualised bodies, resulting in devaluation of their health and obscuring of state-corporate harms caused.

AB - The pharmaceutical industry has long been recognised by criminologists as causing social harms towards individuals and groups, by engaging in unethical and illegal business practices in the pathological pursuit of profit (Braithwaite, 1984/2014; Bakan, 2004). This article argues that the neoliberal state is complicit and contributes to pharmaceutical harms due to its reluctance to effectively prohibit and sanction these (Tombs and Whyte, 2015). Neoliberal national healthcare politics and policies have also created rationale and opportunities for private profit creation by the pharmaceutical industry, and resultant social harms (Harvey, 2005; Dorling, 2014). Using a zemiological approach, this article specifically examines why women as healthcare recipients are disproportionately affected by pharmaceutical harms (Szockyi and Fox, 1996). It argues that women who experience social harms caused by the pharmaceutical industry are perceived primarily in relation to their reproductive and sexualised bodies, resulting in devaluation of their health and obscuring of state-corporate harms caused.

KW - Gender

KW - Neoliberalism

KW - Pharmaceutical Industry

KW - Profit

KW - State-Facilitated Corporate Harm

UR - http://www.europeangroup.org/

UR - http://www.egpress.org/

M3 - Article

VL - 3

JO - Justice, Power and Resistance: The Journal of the European Group for The Study of Deviance and Social Control.

JF - Justice, Power and Resistance: The Journal of the European Group for The Study of Deviance and Social Control.

IS - 1

ER -